Back to results
US 2022/0016106 A1Published application
Compounds and methods useful for treating or preventing hematological cancers
AssigneesThe Broad Institute, Inc., The General Hospital Corporation, President and Fellows of Harvard College, Bayer Pharma Aktiengesellschaft
InventorsDavid B. Sykes, David Scadden, Timothy A. Lewis, Andreas Janzer, Hanna Meyer, Detlef Stöckigt
Life of this patent
Estimating the term…
Abstract
The present invention includes methods of treating patients with acute myeloid leukemia across a range of genetic subtypes with DHODH inhibitors, such as 6-fluoro-2-(2′-fluoro-[1,1′-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid).
Claims7
1-11. (canceled)
A method of treating a hematological cancer in a subject in need thereof comprising:
- (a) administering to the subject a first dose of a dihydroorotate dehydrogenase (DHODH) inhibitor;
- (b) detecting dihydroorotate (DHO) and/or uridine in a biological sample obtained from the subject;
- and
- (c) administering a second dose of a DHODH inhibitor, wherein the amount and or timing of the administration is modified based on the amounts of DHO and/or uridine detected, thereby treating the hematological malignancy in the subject.
1 more element
Dependencies are inferred from the claim text.